Diffuse Large B-cell Lymphoma Prognosis Calculator
Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) enrolled on randomized clinical trials | Semantic Scholar
The International Prognostic Index Is Associated with Outcomes in Diffuse Large B Cell Lymphoma after Chimeric Antigen Receptor T Cell Therapy - Transplantation and Cellular Therapy, Official Publication of the American Society
Gray Zone Lymphoma (GZL) with Features Intermediate between Classical Hodgkin Lymphoma (cHL) and Diffuse Large B-Cell Lymphoma (DLBCL): A Large Retrospective. - ppt download
International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI - ScienceDirect
Diffuse Large B-Cell Lymphoma – Karyopharm Therapeutics
Is NCCN-IPI a Better Prognostic Tool for DLBCL Treated With R-CHOP?
The Korean Journal of Internal Medicine
CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP | Journal of Clinical Oncology
Quantitative Radiomics Features in Diffuse Large B-Cell Lymphoma: Does Segmentation Method Matter? | Journal of Nuclear Medicine
A model to predict the prognosis of diffuse large B-cell lymphoma based on ultrasound images | Scientific Reports
Prephase rituximab/prednisone therapy and aging-related, proinflammatory cytokine milieu in older, vulnerable patients with newly diagnosed diffuse large B-cell lymphoma | Haematologica
Follicular Lymphoma International Prognostic Index (FLIPI). Online calculator | ClinCaseQuest
A new prognostic score for AIDS-related lymphomas in the rituximab-era | Haematologica
Comparative molecular cell-of-origin classification of diffuse large B-cell lymphoma based on liquid and tissue biopsies | Translational Medicine Communications | Full Text
Diffuse Large B-Cell Lymphoma and Related Diseases | Oncohema Key
Survival Rates and Factors That Affect Prognosis (Outlook) for Non-Hodgkin Lymphoma
Diffuse Large B-Cell Lymphoma Risk Score Calculator: A Tool To Accurately Predict Survival Risk And Improve Treatment Decisions
International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI - ScienceDirect
Immunohistochemical Distinction Between Diffuse Large B-Cell... | Download Table
Novel prognostic scoring system for diffuse large B-cell lymphoma
A Clinico-Genotypic Prognostic Index for De Novo Composite Diffuse Large B-Cell Lymphoma Arising from Follicular Lymphoma in Asian patients treated in the Rituximab Era | Scientific Reports
